← Back to Patent Explorer
US3949006A Expired / Lapsed US ⏱️ 0.0 years remaining

Synthesis of vitamin A, intermediates and conversion thereof to vitamin A

Assignee: SCM Glidco Organics Corp
•
Filing: 1973-04-23
•
Granted: 1976-04-06
•
Expires: 1993-04-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A synthesis of novel Vitamin A intermediates from betaionone is described as well as a conversion of the intermediates to Vitamin A. The length of the conjugated aliphatic side chain of beta-ionone is increased while still ultimately obtaining the desired trans form of Vitamin A. In general, beta-ionone is ethynylated to ethynyl-beta-ionol, the hydroxyl of which is etherified to form an ethynyl-terminated, alkoxy-substituted, beta-ionol intermediate. The intermediate is coupled through its copper derivative with a compound like chloro-isopentenyl acetate to produce a C 20 skeleton. By semi-hydrogenation, the acetylenic bond on the C 20 skeleton is converted to an ethylenic bond, and by hydrolysis the terminal ester moiety is converted to a hydroxyl group. Treatment with a strong base removes the alkoxy group to produce Vitamin A.

Inventors

  • 👤 William Oroshnik

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 15:01
CPC Classifications
C; C07; C07C; C07C403/00; C07C403/06; C07C403/08; C07C403/10; C07C2601/00; C07C2601/12; C07C2601/16

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 215 words
A process for synthesizing Vitamin A from beta-ionone by increasing the length of its conjugated aliphatic chain while still obtaining the trans form of Vitamin A, comprising: a. ethynylating beta-ionone to form ethynyl-beta-ionol, b. etherifying the hydroxyl group of said ionol at the tertiary carbon atom to form a compound having the general formula: ##SPC12## in which R is lower alkyl, lower alkenyl, phenyl, aralkyl, c. forming the cuprous acetylenyl derivative of a compound of Formula I, d. coupling said acetylenyl derivative to a reactant having the general formula: ##EQU3## in which R 1 is hydrogen or ##EQU4## R 2 being lower alkyl, phenyl, or aralkyl, and R 3 is halogen to form a compound having the general formula: ##SPC13## e. semi-hydrogenating the acetylenic bond of the compound of Formula III to form a compound having the general formula: ##SPC14## f. subjecting the compound of Formula IV to hydrolysis to convert the terminal ester group to a terminal hydroxyl group to form a compound having the general formula: ##SPC15## and, g. subjecting a compound of Formula V to the presence of a sufficiently strong basic medium to effect 1,4 elimination of ROH therefrom, formation of an additional double bond and conjugation of all five double bonds in the molecule in order to form Vitamin A.
Claim 2
Dependent Claim 215 words
A process for synthesizing Vitamin A from beta-ionone by increasing the length of its conjugated aliphatic chain while still obtaining the trans form of Vitamin A, comprising: a. ethynylating beta-ionone to form ethynyl-beta-ionol, b. etherifying the hydroxyl group of said ionol at the tertiary carbon atom to form a compound having the general formula: ##SPC12## in which R is lower alkyl, lower alkenyl, phenyl, aralkyl, c. forming the cuprous acetylenyl derivative of a compound of Formula I, d. coupling said acetylenyl derivative to a reactant having the general formula: ##EQU3## in which R 1 is hydrogen or ##EQU4## R 2 being lower alkyl, phenyl, or aralkyl, and R 3 is halogen to form a compound having the general formula: ##SPC13## e. semi-hydrogenating the acetylenic bond of the compound of Formula III to form a compound having the general formula: ##SPC14## f. subjecting the compound of Formula IV to hydrolysis to convert the terminal ester group to a terminal hydroxyl group to form a compound having the general formula: ##SPC15## and, g. subjecting a compound of Formula V to the presence of a sufficiently strong basic medium to effect 1,4 elimination of ROH therefrom, formation of an additional double bond and conjugation of all five double bonds in the molecule in order to form Vitamin A.
Claim 3
Dependent Claim 43 words
The process of claim 1 wherein said basic medium is selected from the group consisting of sodamide or potassium amide in liquid ammonia, with or without a co-solvent selected from the group consisting of ether, ethylene diamine, tetrahydrofuran, pentane, hexamethylphosphoramide, and combinations thereof.
Claim 4
Dependent Claim 21 words
The process of claim 1 wherein the hydroxyl group of said ionol is etherified with R 2 SO 4 is hexamethylphosphoramide.
Claim 5
Dependent Claim 11 words
The process of claim 1 wherein R is a methyl group.
Claim 6
Dependent Claim 12 words
The process of claim 4 wherein OR 1 is an acetate group.
Claim 7
Dependent Claim 11 words
The process of claim 1 wherein R is an ethyl group.
Claim 8
Dependent Claim 12 words
The process of claim 6 wherein OR 1 is an acetate group.
Claim 9
Dependent Claim 18 words
The process of claim 1 wherein the compound of Formula III is subjected to hydrolysis prior to semi-hydrogenation.

References Cited (Backward Citations)

US2452386A Cited
US2602092A Cited
US2586305A Cited
US2845462A Cited
US2842600A Cited
US2920103A Cited
US3006968A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-04-06 1979-10-06 1980-04-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-04-06 1983-10-06 1984-04-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-04-06 1987-10-06 1988-04-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag